CAPLYTA

Product NDC: 72060-121
Requested package NDC: 72060-121-40
11-digit product format: 720600121
Labeler code: 72060
Product ID: 72060-121_fa0963da-0db0-41f8-bb1a-153908a8bd77
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: lumateperone
Dosage form: CAPSULE
Route: ORAL
Labeler: Intra-Cellular Therapies, Inc
Application: NDA209500
Marketing category: NDA
Marketing start: 2022-08-09
Substance: LUMATEPERONE
Active strength: 21 mg/1
Pharmacologic classes: Atypical Antipsychotic [EPC]
NDC exclude flag: No
Listing certified through: 2027-12-31
Current FDA listing: Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	RLD / RS	Approval date
N209500-001	CAPLYTA	LUMATEPERONE TOSYLATE	EQ 42MG BASE	CAPSULE / ORAL	RLD, RS	2019-12-20
N209500-002	CAPLYTA	LUMATEPERONE TOSYLATE	EQ 10.5MG BASE	CAPSULE / ORAL	RLD	2022-04-22
N209500-003	CAPLYTA	LUMATEPERONE TOSYLATE	EQ 21MG BASE	CAPSULE / ORAL	RLD	2022-04-22

Orange Book patents#

Current patent rows page 1 of 2 · 97 matching rows.

Application-product, Patent, Expiration table
Application-product	Patent	Expiration	Use code	Coverage / status	Submission date
N209500-001	10464938	2028-03-12		Drug product	2020-01-17
N209500-001	9199995	2029-03-12	U-2713		2020-01-17
N209500-001	9199995	2029-03-12	U-4343		2020-01-17
N209500-001	9586960	2029-03-12		Drug substance, Drug product	2020-01-17
N209500-001	RE48825	2029-03-12		Drug substance, Drug product	2021-12-21
N209500-001	10117867	2029-05-27	U-3271		2022-01-13
N209500-001	9616061	2029-05-27		Drug product	2020-01-17
N209500-001	8648077	2029-12-01		Drug substance, Drug product	2020-01-17
N209500-001	8598119	2029-12-28	U-543	Delist requested	2020-01-17
N209500-001	RE48839	2033-08-19	U-3271		2022-01-05
N209500-001	RE48839	2033-08-19	U-4344		2022-01-05
N209500-001	RE48839	2033-08-19	U-814		2022-01-05
N209500-001	10960009	2034-12-03	U-814		2021-04-20
N209500-001	11026951	2034-12-03	U-3274		2022-01-13
N209500-001	9956227	2034-12-03	U-2714		2020-01-17
N209500-001	12409176	2039-03-15	U-4261		2025-09-17
N209500-001	10695345	2039-08-30	U-543	Drug product	2020-07-16
N209500-001	11690842	2039-08-30	U-3362	Drug product	2023-08-03
N209500-001	11690842	2039-08-30	U-3363	Drug product	2023-08-03
N209500-001	11690842	2039-08-30	U-4341	Drug product	2023-08-03
N209500-001	11806348	2039-08-30	U-3362	Drug product	2023-11-17
N209500-001	11806348	2039-08-30	U-3363	Drug product	2023-11-17
N209500-001	11806348	2039-08-30	U-4341	Drug product	2023-11-17
N209500-001	12070459	2039-08-30	U-3362	Drug product	2024-08-29
N209500-001	12070459	2039-08-30	U-3363	Drug product	2024-08-29
N209500-001	12070459	2039-08-30	U-4341	Drug product	2024-08-29
N209500-001	12128043	2039-08-30	U-3362	Drug product	2024-10-30
N209500-001	12128043	2039-08-30	U-3363	Drug product	2024-10-30
N209500-001	11980617	2039-10-27	U-3940		2024-06-11
N209500-001	11980617	2039-10-27	U-4342		2024-06-11
N209500-001	12090155	2040-07-07	U-4000	Drug product	2024-10-04
N209500-001	11753419	2040-12-10		Drug product, Delist requested	2023-10-11
N209500-001	12122792	2040-12-10	U-4019	Drug product	2024-10-28
N209500-001	12122792	2040-12-10	U-4020	Drug product	2024-10-28
N209500-001	12122792	2040-12-10	U-4340	Drug product	2024-10-28
N209500-001	12410195	2040-12-10		Drug product	2025-09-17
N209500-002	10464938	2028-03-12		Drug product	2022-05-18
N209500-002	9199995	2029-03-12	U-2713		2022-05-18
N209500-002	9199995	2029-03-12	U-4343		2022-05-18
N209500-002	RE48825	2029-03-12		Drug substance	2022-05-18
N209500-002	10117867	2029-05-27	U-3271		2022-05-18
N209500-002	9168258	2029-05-27		Drug product	2023-12-12
N209500-002	9616061	2029-05-27		Drug product	2022-05-18
N209500-002	8648077	2029-12-01		Drug substance, Drug product	2022-05-18
N209500-002	RE48839	2033-08-19	U-3271		2022-05-18
N209500-002	RE48839	2033-08-19	U-4344		2022-05-18
N209500-002	RE48839	2033-08-19	U-814		2022-05-18
N209500-002	11026951	2034-12-03	U-3364		2022-05-18
N209500-002	9956227	2034-12-03	U-2714		2022-05-18
N209500-002	12409176	2039-03-15	U-4261		2025-09-17
N209500-002	10695345	2039-08-30	U-814	Drug product	2022-05-18
N209500-002	11052084	2039-08-30	U-3362	Drug product	2022-05-18
N209500-002	11052084	2039-08-30	U-3363	Drug product	2022-05-18
N209500-002	11052084	2039-08-30	U-4341	Drug product	2022-05-18
N209500-002	11690842	2039-08-30	U-3362	Drug product	2023-08-03
N209500-002	11690842	2039-08-30	U-3363	Drug product	2023-08-03
N209500-002	11690842	2039-08-30	U-4341	Drug product	2023-08-03
N209500-002	11806348	2039-08-30	U-3362	Drug product	2023-11-17
N209500-002	11806348	2039-08-30	U-3363	Drug product	2023-11-17
N209500-002	11806348	2039-08-30	U-4341	Drug product	2023-11-17
N209500-002	11980617	2039-10-27	U-3940		2024-06-11
N209500-002	11980617	2039-10-27	U-4342		2024-06-11
N209500-002	11753419	2040-12-10		Drug product, Delist requested	2023-10-11
N209500-002	12122792	2040-12-10	U-4019	Drug product	2024-10-28
N209500-002	12122792	2040-12-10	U-4020	Drug product	2024-10-28
N209500-002	12122792	2040-12-10	U-4340	Drug product	2024-10-28
N209500-002	12410195	2040-12-10		Drug product	2025-09-17
N209500-003	10464938	2028-03-12		Drug product	2022-05-18
N209500-003	9199995	2029-03-12	U-2713		2022-05-18
N209500-003	9199995	2029-03-12	U-4343		2022-05-18
N209500-003	RE48825	2029-03-12		Drug substance	2022-05-18
N209500-003	10117867	2029-05-27	U-3271		2022-05-18
N209500-003	9616061	2029-05-27		Drug product	2022-05-18
N209500-003	8648077	2029-12-01		Drug substance, Drug product	2022-05-18
N209500-003	RE48839	2033-08-19	U-3271		2022-05-18
N209500-003	RE48839	2033-08-19	U-4344		2022-05-18
N209500-003	RE48839	2033-08-19	U-814		2022-05-18
N209500-003	11026951	2034-12-03	U-3364		2022-05-18
N209500-003	9956227	2034-12-03	U-2714		2022-05-18
N209500-003	12409176	2039-03-15	U-4261		2025-09-17

Orange Book exclusivity#

Current exclusivity rows page 1 of 1 · 6 matching rows.

Application-product, Exclusivity code, Expiration table
Application-product	Exclusivity code	Expiration
N209500-001	I-904	2028-11-05
N209500-001	M-319	2029-04-24
N209500-002	I-904	2028-11-05
N209500-002	M-319	2029-04-24
N209500-003	I-904	2028-11-05
N209500-003	M-319	2029-04-24

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 101 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	RLD / RS	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	N209500-001	CAPLYTA	EQ 42MG BASE	CAPSULE / ORAL	RLD, RS	2019-12-20	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N209500-002	CAPLYTA	EQ 10.5MG BASE	CAPSULE / ORAL	RLD	2022-04-22	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N209500-003	CAPLYTA	EQ 21MG BASE	CAPSULE / ORAL	RLD	2022-04-22	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N209500-001	CAPLYTA	EQ 42MG BASE	CAPSULE / ORAL	RLD, RS	2019-12-20	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N209500-002	CAPLYTA	EQ 10.5MG BASE	CAPSULE / ORAL	RLD	2022-04-22	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N209500-003	CAPLYTA	EQ 21MG BASE	CAPSULE / ORAL	RLD	2022-04-22	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N209500-001	CAPLYTA	EQ 42MG BASE	CAPSULE / ORAL	RLD, RS	2019-12-20	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N209500-002	CAPLYTA	EQ 10.5MG BASE	CAPSULE / ORAL	RLD	2022-04-22	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N209500-003	CAPLYTA	EQ 21MG BASE	CAPSULE / ORAL	RLD	2022-04-22	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N209500-001	CAPLYTA	EQ 42MG BASE	CAPSULE / ORAL	RLD, RS	2019-12-20	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N209500-002	CAPLYTA	EQ 10.5MG BASE	CAPSULE / ORAL	RLD	2022-04-22	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N209500-003	CAPLYTA	EQ 21MG BASE	CAPSULE / ORAL	RLD	2022-04-22	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N209500-001	CAPLYTA	EQ 42MG BASE	CAPSULE / ORAL	RLD, RS	2019-12-20	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N209500-002	CAPLYTA	EQ 10.5MG BASE	CAPSULE / ORAL	RLD	2022-04-22	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N209500-003	CAPLYTA	EQ 21MG BASE	CAPSULE / ORAL	RLD	2022-04-22	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N209500-001	CAPLYTA	EQ 42MG BASE	CAPSULE / ORAL	RLD, RS	2019-12-20	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N209500-002	CAPLYTA	EQ 10.5MG BASE	CAPSULE / ORAL	RLD	2022-04-22	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N209500-003	CAPLYTA	EQ 21MG BASE	CAPSULE / ORAL	RLD	2022-04-22	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N209500-001	CAPLYTA	EQ 42MG BASE	CAPSULE / ORAL	RLD, RS	2019-12-20	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N209500-002	CAPLYTA	EQ 10.5MG BASE	CAPSULE / ORAL	RLD	2022-04-22	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N209500-003	CAPLYTA	EQ 21MG BASE	CAPSULE / ORAL	RLD	2022-04-22	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N209500-001	CAPLYTA	EQ 42MG BASE	CAPSULE / ORAL	RLD, RS	2019-12-20	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N209500-002	CAPLYTA	EQ 10.5MG BASE	CAPSULE / ORAL	RLD	2022-04-22	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N209500-003	CAPLYTA	EQ 21MG BASE	CAPSULE / ORAL	RLD	2022-04-22	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N209500-001	CAPLYTA	EQ 42MG BASE	CAPSULE / ORAL	RLD, RS	2019-12-20	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N209500-002	CAPLYTA	EQ 10.5MG BASE	CAPSULE / ORAL	RLD	2022-04-22	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N209500-003	CAPLYTA	EQ 21MG BASE	CAPSULE / ORAL	RLD	2022-04-22	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N209500-001	CAPLYTA	EQ 42MG BASE	CAPSULE / ORAL	RLD, RS	2019-12-20	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N209500-002	CAPLYTA	EQ 10.5MG BASE	CAPSULE / ORAL	RLD	2022-04-22	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N209500-003	CAPLYTA	EQ 21MG BASE	CAPSULE / ORAL	RLD	2022-04-22	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N209500-001	CAPLYTA	EQ 42MG BASE	CAPSULE / ORAL	RLD, RS	2019-12-20	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N209500-002	CAPLYTA	EQ 10.5MG BASE	CAPSULE / ORAL	RLD	2022-04-22	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N209500-003	CAPLYTA	EQ 21MG BASE	CAPSULE / ORAL	RLD	2022-04-22	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N209500-001	CAPLYTA	EQ 42MG BASE	CAPSULE / ORAL	RLD, RS	2019-12-20	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N209500-002	CAPLYTA	EQ 10.5MG BASE	CAPSULE / ORAL	RLD	2022-04-22	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N209500-003	CAPLYTA	EQ 21MG BASE	CAPSULE / ORAL	RLD	2022-04-22	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N209500-001	CAPLYTA	EQ 42MG BASE	CAPSULE / ORAL	RLD, RS	2019-12-20	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N209500-002	CAPLYTA	EQ 10.5MG BASE	CAPSULE / ORAL	RLD	2022-04-22	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N209500-003	CAPLYTA	EQ 21MG BASE	CAPSULE / ORAL	RLD	2022-04-22	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N209500-001	CAPLYTA	EQ 42MG BASE	CAPSULE / ORAL	RLD, RS	2019-12-20	`301d65b070ca…`

Observed Orange Book patent history#

Patent history page 1 of 50 · 1,973 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Patent	Expiration	Use code	Coverage / status	Submission date	Source SHA-256
2026-09-14 22:38:34	2026-08	N209500-001	10464938	2028-03-12		Drug product	2020-01-17	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N209500-001	9199995	2029-03-12	U-2713		2020-01-17	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N209500-001	9199995	2029-03-12	U-4343		2020-01-17	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N209500-001	9586960	2029-03-12		Drug substance, Drug product	2020-01-17	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N209500-001	RE48825	2029-03-12		Drug substance, Drug product	2021-12-21	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N209500-001	10117867	2029-05-27	U-3271		2022-01-13	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N209500-001	9616061	2029-05-27		Drug product	2020-01-17	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N209500-001	8648077	2029-12-01		Drug substance, Drug product	2020-01-17	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N209500-001	8598119	2029-12-28	U-543	Delist requested	2020-01-17	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N209500-001	RE48839	2033-08-19	U-4344		2022-01-05	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N209500-001	RE48839	2033-08-19	U-3271		2022-01-05	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N209500-001	RE48839	2033-08-19	U-814		2022-01-05	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N209500-001	10960009	2034-12-03	U-814		2021-04-20	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N209500-001	11026951	2034-12-03	U-3274		2022-01-13	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N209500-001	9956227	2034-12-03	U-2714		2020-01-17	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N209500-001	12409176	2039-03-15	U-4261		2025-09-17	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N209500-001	10695345	2039-08-30	U-543	Drug product	2020-07-16	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N209500-001	11690842	2039-08-30	U-4341	Drug product	2023-08-03	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N209500-001	11690842	2039-08-30	U-3362	Drug product	2023-08-03	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N209500-001	11690842	2039-08-30	U-3363	Drug product	2023-08-03	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N209500-001	11806348	2039-08-30	U-3362	Drug product	2023-11-17	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N209500-001	11806348	2039-08-30	U-3363	Drug product	2023-11-17	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N209500-001	11806348	2039-08-30	U-4341	Drug product	2023-11-17	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N209500-001	12070459	2039-08-30	U-3362	Drug product	2024-08-29	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N209500-001	12070459	2039-08-30	U-3363	Drug product	2024-08-29	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N209500-001	12070459	2039-08-30	U-4341	Drug product	2024-08-29	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N209500-001	12128043	2039-08-30	U-3362	Drug product	2024-10-30	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N209500-001	12128043	2039-08-30	U-3363	Drug product	2024-10-30	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N209500-001	11980617	2039-10-27	U-4342		2024-06-11	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N209500-001	11980617	2039-10-27	U-3940		2024-06-11	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N209500-001	12090155	2040-07-07	U-4000	Drug product	2024-10-04	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N209500-001	11753419	2040-12-10		Drug product, Delist requested	2023-10-11	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N209500-001	12122792	2040-12-10	U-4019	Drug product	2024-10-28	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N209500-001	12122792	2040-12-10	U-4020	Drug product	2024-10-28	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N209500-001	12122792	2040-12-10	U-4340	Drug product	2024-10-28	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N209500-001	12410195	2040-12-10		Drug product	2025-09-17	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N209500-002	10464938	2028-03-12		Drug product	2022-05-18	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N209500-002	9199995	2029-03-12	U-4343		2022-05-18	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N209500-002	9199995	2029-03-12	U-2713		2022-05-18	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N209500-002	RE48825	2029-03-12		Drug substance	2022-05-18	`84e616aacf4f…`

Observed Orange Book exclusivity history#

Exclusivity history page 1 of 4 · 127 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Exclusivity code	Expiration	Source SHA-256
2026-09-14 22:38:34	2026-08	N209500-001	I-904	2028-11-05	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N209500-001	M-319	2029-04-24	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N209500-002	I-904	2028-11-05	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N209500-002	M-319	2029-04-24	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N209500-003	I-904	2028-11-05	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N209500-003	M-319	2029-04-24	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N209500-001	I-904	2028-11-05	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N209500-001	M-319	2029-04-24	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N209500-002	I-904	2028-11-05	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N209500-002	M-319	2029-04-24	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N209500-003	I-904	2028-11-05	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N209500-003	M-319	2029-04-24	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N209500-001	I-904	2028-11-05	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N209500-002	I-904	2028-11-05	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N209500-003	I-904	2028-11-05	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N209500-001	I-904	2028-11-05	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N209500-002	I-904	2028-11-05	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N209500-003	I-904	2028-11-05	`31067a03dcf5…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N209500-001	I-882	2024-12-17	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N209500-001	NCE	2024-12-20	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N209500-002	NCE	2024-12-20	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N209500-003	NCE	2024-12-20	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N209500-001	I-882	2024-12-17	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N209500-001	NCE	2024-12-20	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N209500-002	NCE	2024-12-20	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N209500-003	NCE	2024-12-20	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N209500-001	I-882	2024-12-17	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N209500-001	NCE	2024-12-20	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N209500-002	NCE	2024-12-20	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N209500-003	NCE	2024-12-20	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N209500-001	I-882	2024-12-17	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N209500-001	NCE	2024-12-20	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N209500-002	NCE	2024-12-20	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N209500-003	NCE	2024-12-20	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N209500-001	I-882	2024-12-17	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N209500-001	NCE	2024-12-20	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N209500-002	NCE	2024-12-20	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N209500-003	NCE	2024-12-20	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N209500-001	I-882	2024-12-17	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N209500-001	NCE	2024-12-20	`79d66fd596c7…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product: Yes
Brand name base: CAPLYTA
Listing expiration: 2027-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
LUMATEPERONE	21 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
70BSQ12069	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 6 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
2275607	Internal RxNorm lookup
2275613	Internal RxNorm lookup
2607529	Internal RxNorm lookup
2607531	Internal RxNorm lookup
2607533	Internal RxNorm lookup
2607535	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
db730b06-6351-47fd-8183-e61e61bbead5	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
be572206-b036-4503-934b-e830606fefae	Product name	1	20200107

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
72060-121-07	CAPLYTA	7 in 1 BOTTLE	CAPSULE	7		26
72060-121-40	CAPLYTA	30 in 1 BOTTLE	CAPSULE	30		26

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
72060-121-40	EA - Each	72060-121	69afba87-264d-4b03-ae34-a548c1b0791b	1	2022-08-04

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
72060-121	CAPLYTA (LUMATEPERONE) CAPSULE [INTRA-CELLULAR THERAPIES, INC]	18	Current NDC, Legacy NDC, 2 package rows	20240927_db730b06-6351-47fd-8183-e61e61bbead5.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
CAPLYTA	LUMATEPERONE	Intra-Cellular Therapies, Inc	db730b06-6351-47fd-8183-e61e61bbead5	2025-06-20	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (NDA): 209500 application number: NDA209500 ndc (package): 72060-121-40 ndc (product): 72060-121 ndc11 (package): 72060012140

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
70BSQ12069	LUMATEPERONE	313368-91-1	LUMATEPERONE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
2607531	CAPLYTA 10.5 MG Oral Capsule	PSN	db730b06-6351-47fd-8183-e61e61bbead5	27
2607535	CAPLYTA 21 MG Oral Capsule	PSN	db730b06-6351-47fd-8183-e61e61bbead5	27
2275613	CAPLYTA 42 MG Oral Capsule	PSN	db730b06-6351-47fd-8183-e61e61bbead5	27
2607529	lumateperone 10.5 MG Oral Capsule	PSN	db730b06-6351-47fd-8183-e61e61bbead5	27
2607533	lumateperone 21 MG Oral Capsule	PSN	db730b06-6351-47fd-8183-e61e61bbead5	27
2275607	lumateperone 42 MG Oral Capsule	PSN	db730b06-6351-47fd-8183-e61e61bbead5	27
2607531	lumateperone 10.5 MG Oral Capsule [Caplyta]	SBD	db730b06-6351-47fd-8183-e61e61bbead5	27
2607535	lumateperone 21 MG Oral Capsule [Caplyta]	SBD	db730b06-6351-47fd-8183-e61e61bbead5	27
2275613	lumateperone 42 MG Oral Capsule [Caplyta]	SBD	db730b06-6351-47fd-8183-e61e61bbead5	27
2607529	lumateperone 10.5 MG Oral Capsule	SCD	db730b06-6351-47fd-8183-e61e61bbead5	27
2607533	lumateperone 21 MG Oral Capsule	SCD	db730b06-6351-47fd-8183-e61e61bbead5	27
2275607	lumateperone 42 MG Oral Capsule	SCD	db730b06-6351-47fd-8183-e61e61bbead5	27
2607531	Caplyta 10.5 MG Oral Capsule	SY	db730b06-6351-47fd-8183-e61e61bbead5	27
2607535	Caplyta 21 MG Oral Capsule	SY	db730b06-6351-47fd-8183-e61e61bbead5	27
2275613	Caplyta 42 MG (equivalent to lumateperone tosylate 60 MG) Oral Capsule	SY	db730b06-6351-47fd-8183-e61e61bbead5	27
2275613	Caplyta 42 MG Oral Capsule	SY	db730b06-6351-47fd-8183-e61e61bbead5	27
2607529	lumateperone 10.5 MG (as lumateperone tosylate 15 MG) Oral Capsule	SY	db730b06-6351-47fd-8183-e61e61bbead5	27
2607533	lumateperone 21 MG (as lumateperone tosylate 30 MG) Oral Capsule	SY	db730b06-6351-47fd-8183-e61e61bbead5	27
2275607	lumateperone 42 MG (equivalent to lumateperone tosylate 60 MG) Oral Capsule	SY	db730b06-6351-47fd-8183-e61e61bbead5	27

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
72060-121-40	72060012140	30 CAPSULE in 1 BOTTLE (72060-121-40)	30 capsule	2022-08-09	0000-00-00	No	No	Current